Melatonin High Dose 150mg

This is a product used by providers in conjunction with specific health needs. Note: This is not to be used for insomnia. 

Effective radioprotective actions show that including melatonin as an adjuvant in radiation therapy may decrease the normal tissue damage induced by irradiation, which leads to more tumor control by use of higher doses of irradiation during radiotherapy. Furthermore, due to its antitumor and radiosensitizing properties, treatment with melatonin is likely to increase damage to the tumor. https://www.hindawi.com/journals/bmri/2014/578137/#conclusion

Supplement Facts

Melatonin High Dose 150mg Roles: 

Mills, E., P. Wu, et al. J Pineal Res. 2005 November;39(4):360-6.

Mediavilla MD1 , Sanchez-Barcelo EJ, et al. Curr Med Chem 2010;17(36):4462-81. 

 Some other studies of interest showing benefits of high doses of melatonin:

Govender, Jenelle, Ben Loos, and Anna-Mart Engelbrecht. “Melatonin: a protective role against doxorubicin-induced cardiotoxicity.” Future Oncology 11.14 (2015): 2003-2006.

Mills, Edward, et al. “Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta‐analysis.” Journal of pineal research 39.4 (2005): 360-366.

Lissoni, P., et al. “Increased survival time in brain glioblastomas by a radio neuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.” Oncology 53.1 (1996): 43-46.

Thomas, Charles R., Russel J. Reiter, and Terence S. Herman. “Melatonin: from basic research to cancer treatment clinics.” Journal of Clinical Oncology 20.10 (2002): 2575-2601.

Srinivasan, Venkataramanujan, et al. “Therapeutic actions of melatonin in cancer: possible mechanisms.” Integrative Cancer Therapies 7.3 (2008): 189-203.

Blask, David E., Leonard A. Sauer, and Robert T. Dauchy. “Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.” Current topics in medicinal chemistry 2.2 (2002): 113-132.

Conti, Ario, and Georges JM Maestroni. “The clinical neuroimmunotherapeutic role of melatonin in oncology.” Journal of pineal research 19.3 (1995): 103-110.

Alonso‐González, Carolina, et al. “Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double‐strand DNA break repair.” Journal of pineal research 58.2 (2015): 189-197.

Alonso-González, Carolina, et al. “Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.” Cancer letters 370.1 (2016): 145-152.

Loh, D., & Reiter, R. J. (2023). Light, water, and melatonin: The synergistic regulation of phase separation in dementia. International Journal of Molecular Sciences, 24(6), 5835\ https://doi.org/10.3390/ijms24065835

Tavakoli, Maryam. “Kidney protective effects of melatonin.” Journal of Nephropharmacology 3.1 (2015).